Affiliation:
1. Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Aljouf 2014, Saudi Arabia
Abstract
Abstract:
Individuals suffering from mental illnesses, unfortunately, have a shorter lifespan. An
increase in mortality rates is primarily due to physical illness, unhealthy lifestyle, and associated
comorbidities. Antipsychotic medications, previously known as tranquilizers, antipsychotics, or
neuroleptics, can alleviate or attenuate symptoms related to psychosis, delusion, and/or hallucinations
and are used in the treatment of psychosis, schizophrenia, bipolar disorder, depression, or
Alzheimer's disease. Within hours to days, these medications alleviate symptoms and reduce confusion
in individuals with psychosis; however, the full effect may take longer than usual in some
cases. Importantly, these drugs do not cure the disease, but only treat the symptoms of the disease.
The treatment is adjusted to reduce any psychotic symptoms while keeping the adverse effects to a
minimum level. Antipsychotics may lead to increased risk of diseases, including but not limited to,
diabetes, obesity, metabolic disorders, cardiovascular, renal, or respiratory disorders. Improved
dosages, polypharmacy, and age-specific treatment play an important role in limiting the comorbidities,
as well as the side effects. Further research and clinical attention are required to understand
the functioning of these medications. The review focuses on the use of antipsychotic medications
in different diseases and their effect on mental health.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Pharmacology,Toxicology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献